STOCK TITAN

EMERGENT HEALTH CORP - EMGE STOCK NEWS

Welcome to our dedicated page for EMERGENT HEALTH news (Ticker: EMGE), a resource for investors and traders seeking the latest updates and insights on EMERGENT HEALTH stock.

Emergent Health Corp., now known as Apollo Biowellness, Inc., is a holding company centered on regenerative medicine distributed to medical offices, clinics, and consumers. With subsidiaries like Evolutionary Biologics, Integrative Practice Solutions LLC, and Juventix Regenerative Medical LLC, they are venturing into the $5.6 trillion Global Health & Wellness Market. Their focus includes skin care, wound care, cosmetics, regenerative aesthetics, hair growth, ED, longevity/anti-aging, osteoarthritis, and more. With FDA approval pending, the company anticipates growth in skin care and hair products utilizing human exosomes.

Wholistic Brands, a subsidiary of Emergent, epitomizes superior natural formulations from plant-based ingredients, including shelf-stable plant-based exosomes. It aligns with the parent company's objectives and is establishing a direct-to-consumer business around holistic health. The company is under new management, with Jim Morrison as Chairman and President/CEO, bringing his expertise in personal care and biologics to the fore. Morrison's industry experience and leadership are set to steer Emergent Health Corp. into a new era of growth and innovation.

Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) has appointed Jim Morrison, former President of L'Oréal, as its new CEO. Morrison, known for driving over 20% year-over-year growth and leading successful acquisitions like Redken and Matrix, aims to elevate Emergent in the 'Health and Wellness' sector. His vision focuses on developing a robust portfolio of wellness products, including offerings for pets. Emergent operates in the Regenerative Health Space, distributing products through influencers and e-commerce channels.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.24%
Tags
none
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK: EMGE) has acquired Regen Biowellness, Inc., expanding its footprint in the plant-based and regenerative medical sectors. The deal involves the issuance of preferred stock and other financial considerations. Industry veteran Jim Morrison, former L'Oréal President, joins Emergent's Board of Directors. This acquisition aims to bolster the company's product portfolio in both human and pet health, focusing on regenerative medicine and OTC products, while leveraging Morrison's extensive industry experience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-32.64%
Tags
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) has retained Imagemme, a leading branding studio, to develop its new brand, "The Wholistic Company". This initiative aims to unify its health, wellness, and regenerative products and establish effective marketing strategies for multi-channel sales. The company plans to complete acquisitions of Regen Biowellness, Evolutionary Biologics, and Fusion Specialty Pharmacies by August 2022. CEO James W. Zimbler expresses optimism for the brand's potential to become a household name.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.77%
Tags
none
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) announces its acquisition of Evolutionary Biologics, specializing in regenerative biological products. The partnership with By Design Medical aims to commercially launch their flagship product, Exo Elixir TM, a regenerative serum derived from dermal fibroblast stem cells. The biologics market is projected to grow from US $366.43 billion in 2021 to over US $719.84 billion by 2030. The acquisition is expected to finalize within two weeks, enhancing Emergent's market position in aesthetics and regenerative medicine.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.03%
Tags
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) is set to acquire Regen Biowellness, Inc., a distributor in the plant-based and regenerative medical fields, with the acquisition expected to close around August 1, 2022. The acquisition follows Regen's recent resolution of its bankruptcy litigation. Jim Morrison, former President of L'Oréal, will join Emergent's Board and serve as CEO post-acquisition. This acquisition aims to expand Emergent's portfolio in the wellness sector, including human and pet products, enhancing growth and shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.38%
Tags
management acquisition
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) has signed a Letter of Intent to acquire Evolutionary Biologics, Inc., focusing on regenerative products like Evo Hybrid and HydrEyes. The transaction involves equity issuance and capital investment to enhance sales and operations. Former L'Oréal President Jim Morrison will assume the role of full-time CEO. This acquisition aims to position Emergent as a leader in plant-based wellness and regenerative health, targeting consumer awareness through innovative marketing strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.43%
Tags
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) announces its expected acquisition of Regen Biowellness, aiming to re-launch the FDA Registered Immune Booster supplement ImmunaZin™. This supplement, featuring a unique blend of 44 amino acid fragments, enhances T helper cell production to combat pathogens. Emergent plans to partner with wholesale and multi-level marketing firms for distribution and is set to introduce ImmunaZin™ in Q4 2022. The merger aims to position Emergent-Regen as a leader in the plant-based wellness sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.96%
Tags
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK: EMGE) has announced a joint venture with Nutralife Biosciences to co-produce and market nutraceutical products. Nutralife, a seasoned player in the nutraceutical and skincare industry, will enhance Emergent's distribution capabilities through its established production and marketing platforms. This partnership is expected to boostEmergent's reach in the health and wellness sector and enhance the availability of its PharmaZu pet products. The official launch of PharmaZu's website is set for August 15, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
-
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) announced a Letter of Intent to acquire Regen Biowellness, Inc., expanding its portfolio in the plant-based and regenerative medical fields. Jim Morrison, former President of L'Oréal, will join Emergent's management team. The deal aims to integrate Regen's patent-protected products including Immuniain™ and various cannabinoid compositions into Emergent's offerings. The acquisition is expected to close by mid-to-end July 2022, following the dismissal of Regen's bankruptcy petition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
81.11%
Tags
none
Rhea-AI Summary

Emergent Health Corp. (OTC PINK:EMGE) has executed a Binding Letter of Intent to acquire Fusion Specialty Pharmacy, pending financing and definitive agreements. In 2021, Fusion reported revenues of $3,801,497, reflecting a near 100% increase from 2020. This acquisition aims to close in the 3rd quarter of 2022, enabling Emergent to expand its online pet medication services through PharmaZu, Inc., and to enhance its operational capabilities across all states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
198.75%
Tags

FAQ

What is the current stock price of EMERGENT HEALTH (EMGE)?

The current stock price of EMERGENT HEALTH (EMGE) is $0.0014 as of September 13, 2024.

What is the market cap of EMERGENT HEALTH (EMGE)?

The market cap of EMERGENT HEALTH (EMGE) is approximately 597.7K.

What is Emergent Health Corp. now known as?

Emergent Health Corp. is now known as Apollo Biowellness, Inc.

What is the main focus of Apollo Biowellness?

Apollo Biowellness is centered on regenerative medicine distributed to medical offices, clinics, and consumers.

What subsidiaries are part of the company?

The company has subsidiaries like Evolutionary Biologics, Integrative Practice Solutions LLC, and Juventix Regenerative Medical LLC.

What markets is Apollo Biowellness targeting?

Apollo Biowellness is venturing into the $5.6 trillion Global Health & Wellness Market with products like skin care, cosmetics, regenerative aesthetics, and more.

What is Wholistic Brands?

Wholistic Brands is a subsidiary that focuses on natural formulations from plant-based ingredients, including shelf-stable plant-based exosomes.

Who is the new Chairman and President/CEO of Emergent Health Corp.?

Jim Morrison is the new Chairman and President/CEO of Emergent Health Corp.

What is Jim Morrison's background in the industry?

Jim Morrison brings extensive experience in personal care and biologics, having held key positions in leading companies like L'Oreal and Graham Webb.

What growth opportunities does Apollo Biowellness anticipate?

The company foresees significant growth with FDA approval pending for skin care and hair products using human exosomes.

How is Emergent Health Corp. positioned for the future?

Under the new management and innovative leadership of Jim Morrison, Emergent Health Corp. is poised for growth and success in the health and wellness sector.

What is the distribution strategy of Emergent Health Corp.?

Emergent Health Corp. distributes its products online and through 'Content Based Shopping' using 'Influencers' to position products successfully in the US and internationally.

Are Emergent Health Corp. products FDA approved?

The company asserts that its products are not approved by the FDA to diagnose, treat, cure, or prevent diseases.

EMERGENT HEALTH CORP

OTC:EMGE

EMGE Rankings

EMGE Stock Data

597.73k
58.10M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
King of Prussia